Poolbeg Pharma
from OTCQB Podcast Hosted by OTC Markets Group
Poolbeg Pharma (OTCQB: POLBF) is a clinical stage infectious disease pharmaceutical company with a capital light clinical model which is looking to develop multiple products faster and more cost effectively than the conventional biotech model. CEO Jeremy Skillington joins us to discuss how the Covid-19 pandemic has impacted the company's research on infectious diseases. View Podcast Transcript for Poolbeg Pharma
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 13 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on August 15, 2022.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.